DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación
Artículo científico (JournalArticle)
SARS-CoV-2 ORF7a drives mitochondrial dysfunction via PDK4 activation and complex I inhibition
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection reprograms host metabolism to favor viral replication and immune evasion, yet the contribution of accessory proteins remains poorly defined. Here, we characterize the metabolic effects of the SARS-CoV-2 accessory protein ORF7a. Lentiviral expression of ORF7a in human lung epithelial (A549) and monocytic (THP1) cells, combined with integrated transcriptomic, proteomic, and metabolomic analyses, revealed marked dysregulation of glucose and lipid metabolism. ORF7a impaired mitochondrial oxidative phosphorylation, reducing basal and maximal respiration, inducing mitochondrial depolarization, and increasing reactive oxygen species. Mechanistically, ORF7a upregulated pyruvate dehydrogenase kinase 4 (PDK4), enhancing phosphorylation of the pyruvate dehydrogenase complex and suppressing pyruvate oxidation. However, pharmacological PDK4 inhibition failed to restore respiratory function. High-resolution respirometry identified complex I dysfunction, while Blue Native-PAGE revealed defective assembly of respiratory supercomplexes. Together, these findings demonstrate that ORF7a disrupts mitochondrial metabolism through enzymatic regulation and destabilization of the respiratory chain, highlighting mitochondria as a target of SARS-CoV-2-induced metabolic reprogramming., This research work was funded by the European Commission – NextGenerationEU (Regulation EU 2020/2094) through CSIC's Global Health Platform (PTI+ Salud Global) (COVID-19-117 and SGL2103015), Junta de Andalucía (CV20-20089) and Spanish Ministry of Science projects (PID2021-123399OB-I00 and PID2024-162356OB-I00). TGG is recipient of a Ramón y Cajal contract (RYC2021-031614-I) funded by MCIN/AEU/10.13039/501100011033 and NextGenerationEU/PRTR. RFR is a recipient of a “Contrato Predoctoral para Personal Investigador en Formación (PIF),” University of Córdoba, and has been supported by a PTI + Salud Global fellowship to undertake a predoctoral stay. LMSM was funded by BIO276 (University of Córdoba and Junta de Andalucía). We would like to thank Eduardo Chicano-Galvez and Ángela Peralbo-Molina from IMIBIC Mass Spectrometry and Molecular Imaging Unit (IMSMI) for performing the metabolomic analysis; Carlos Fuentes-Almagro from the Proteomics Facility at Research Support Central Service, University of Cordoba (SCAI-UCO), for sample preparation and proteomic analysis; and Sonia Zuñiga from CNB for kindly providing RNA samples from SARS-CoV-2 infected A549-ACE2 cells., Peer reviewed
Proyecto:
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-123399OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2024-2027 PID2024-162356OB-I00
,
AEI / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 RYC2021-031614-I
DOI: http://hdl.handle.net/10261/443501, https://api.elsevier.com/content/abstract/scopus_id/105045732599
HANDLE: http://hdl.handle.net/10261/443501, https://api.elsevier.com/content/abstract/scopus_id/105045732599